Skip to main content

Advertisement

SpringerLink
Log in

The effect of oral solifenacin succinate treatment on intraocular pressure: glaucoma paradox during overactive bladder treatment

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

Anticholinergic medication is the mainstay of pharmacotherapy for overactive bladder (OAB). The aim of the study is to investigate the effect of oral solifenacin succinate on intraocular pressure (IOP) in female OAB patients and to discuss the ocular drawbacks during treatment.

Methods

The female patients with a clinical diagnosis of OAB in whom use of oral solifenacin succinate 5 mg/day (group I) and age-matched healthy female subjects (group II) underwent complete ophthalmological examination, including IOP measurement at the beginning of the oral treatment and after 4 weeks. The patients with a history of previous ocular surgery and those with ocular diseases besides refraction disorders and presbyopia were excluded.

Results

The data from the right eyes of 60 consecutive patients in group I and 30 consecutive patients in group II were used for analysis. No statistically significant change was detected in the IOP (from 16.05 ± 2.30 mmHg to 16.30 ± 2.25 mmHg at the 4th week in group I, p = 0.160; from 15.60 ± 2.14 mmHg to 15.60 ± 2.09 mmHg at the 4th week in group II, p = 0.864) of the eyes in both groups.

Conclusions

Since the power of the study is not enough to draw a clear conclusion, a 4-week course of solifenacin succinate treatment in women with OAB seemed to have no clinically significant effect on IOP values. Further larger studies are needed to determine the effect of anticholinergics on anterior chamber parameters and to evaluate their safety in glaucoma patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abrams P, Cardozo L, Fall M (2003) Standardisation Sub-Committee of the International Continence Society. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61(1):37–49

    Article  PubMed  Google Scholar 

  2. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5–26. doi:10.1007/s00192-009-0976-9

    Article  PubMed  Google Scholar 

  3. Gormley EA, Lightner DJ, Burgio KL (2012) American Urological Association; Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol 188(6 Suppl):2455–2463

    Article  PubMed  Google Scholar 

  4. Andersson KE (2004) Antimuscarinics for treatment of overactive bladder. Lancet Neurol 3(1):46–53

    Article  PubMed  CAS  Google Scholar 

  5. Tripathi RC, Tripathi BJ, Haggerty C (2003) Drug-induced glaucomas: mechanism and management. Drug Saf 26(11):749–767

    Article  PubMed  CAS  Google Scholar 

  6. Garely AD, Kaufman JM, Sand PK et al (2006) Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT). Clin Ther 28(11):1935–1946

    Article  PubMed  CAS  Google Scholar 

  7. Sung VC, Corridan PG (1998) Acute-angle closure glaucoma as a side-effect of oxybutynin. Br J Urol 81(4):634–635

    Article  PubMed  CAS  Google Scholar 

  8. Ouslander JG, Blaustein J, Connor A et al (1988) Pharmacokinetics and clinical effects of oxybutynin in geriatric patients. J Urol 140(1):47–50

    PubMed  CAS  Google Scholar 

  9. Altan-Yaycioglu R, Yaycioglu O, Aydin Akova Y et al (2005) Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial. Br J Clin Pharmacol 59(5):588–592

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  10. Frischmeyer KJ, Miller PE, Bellay Y et al (1993) Parenteral anticholinergics in dogs with normal and elevated intraocular pressure. Vet Surg 22(3):230–234

    Article  PubMed  CAS  Google Scholar 

  11. Homma Y, Kakizaki H, Gotoh M et al (2003) Epidemiologic survey on urination. J Jpn Neurogenic Bladder Soc 14:266–277

    Google Scholar 

  12. Iwase A (2003) The prevalence of glaucoma in Japan. Ganka 45:733–739

    Google Scholar 

  13. Kato K, Furuhashi K, Suzuki K et al (2007) Overactive bladder and glaucoma: a survey at outpatient clinics in Japan. Int J Urol 14(7):595–597

    Article  PubMed  Google Scholar 

  14. Kato K, Yoshida K, Suzuki K et al (2005) Managing patients with an overactive bladder and glaucoma: a questionnaire survey of Japanese urologists on the use of anticholinergics. BJU Int 95(1):98–101

    Article  PubMed  Google Scholar 

  15. Fink AM, Aylward GW (1995) Buscopan and glaucoma: a survey of current practice. Clin Radiol 50(3):160–164

    Article  PubMed  CAS  Google Scholar 

Download references

Financial disclaimer and conflicts of interest

None.

Author information

Authors and Affiliations

  1. Ulucanlar Eye Training and Research Hospital, Ophthalmology Department, Ankara, Turkey

    Mehmet Ali Sekeroglu

  2. Etlik Zubeyde Hanim Maternity and Research Hospital, Ophthalmology Department, Ankara, Turkey

    Emre Hekimoglu & İkbal Seza Petricli

  3. Etlik Zubeyde Hanim Maternity and Research Hospital, Urogynecology Department, Ankara, Turkey

    Yasemin Tasci & Ismail Dolen

  4. Biostatistics Department, Hacettepe University School of Medicine, Ankara, Turkey

    Umut Arslan

Authors
  1. Mehmet Ali Sekeroglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emre Hekimoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. İkbal Seza Petricli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasemin Tasci
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ismail Dolen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Umut Arslan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mehmet Ali Sekeroglu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sekeroglu, M.A., Hekimoglu, E., Petricli, İ.S. et al. The effect of oral solifenacin succinate treatment on intraocular pressure: glaucoma paradox during overactive bladder treatment. Int Urogynecol J 25, 1479–1482 (2014). https://doi.org/10.1007/s00192-014-2396-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-014-2396-8

Keywords

Search

Navigation